by admin | Oct 29, 2026 | Research & Productivity
Ask most people how long it takes to turn a promising lab discovery into an actual medicine, and they usually guess a year or two. The real answer is closer to ten or twelve years, and most of that time isn’t spent on dramatic breakthroughs. It’s spent on paperwork, repeated lab tests, and narrowing down thousands of possible molecules to the handful worth pursuing.
That’s exactly the part of the process Anthropic just showed its Claude models chipping away at. On October 27, 2026, the company published detailed results from deep research partnerships with six drug developers, plus an early look at a drug program it’s running itself. It’s one of the clearest real-world looks yet at what “AI for science” actually means once you get past the slogan.
What Anthropic Actually Announced
The partnerships involve BigHat Biosciences, Bristol Myers Squibb, Divergence Labs, Enveda, Generate Biomedicines, and The Column Group. Anthropic is careful to frame all of this as early and mostly preclinical work, not finished cures. But the specific numbers in each case study are worth slowing down for, because they show AI being used for genuinely technical science work, not just summarizing PDFs.
Designing a Smaller, Stronger Cancer Therapy
Generate Biomedicines is trying to make CAR T-cell therapy, which has mostly worked against blood cancers, effective against solid tumors too. Six of its scientists used Claude Code to redesign a key genetic component of the therapy. One of the resulting designs was about 70% shorter than the standard version. When tested in the lab, it let immune cells produce roughly ten times as many receptors, killed tumor cells more efficiently, and stayed active in the body longer. (You can read more about how researchers are approaching solid-tumor CAR T-cell therapy at the National Institutes of Health.)
Thousands of Antibody Designs in About a Month
Divergence Labs is working on food allergy treatments that physically detach the IgE antibody from immune cells, rather than just neutralizing it in the bloodstream. Claude turned the team’s scientific goals into a design plan, then largely on its own generated roughly 35,000 antibody designs over about a month. Out of those, researchers found three strong binders and twenty designs that could successfully dislodge IgE, with three of those twenty outperforming the standard allergy medication in early tests.
Catching What Human Reviewers Missed
Not every case study is about inventing new molecules. Enveda’s manufacturing chemists were spending up to 75% of their time on compliance paperwork instead of chemistry. After connecting their documents to Claude, it reviewed 1,061 pages, caught all eleven issues human reviewers had already found, and flagged seven more that had been missed. Review time dropped from over 25 hours to under three. Claude also drafted a regulatory document in four hours that would normally take about three months by hand.
Important tip: if you work in a field with heavy documentation (regulatory filings, compliance reports, research write-ups), this Enveda example is the more realistic near-term use of AI than “AI invents a cure.” Document review and drafting is where the time savings show up first, for almost any industry.
Anthropic Is Also Building Its Own Medicine
Maybe the most human part of the announcement is Mithril Medicine, a company Anthropic acquired that started as a one-person operation. Its founder, Cody Tranbarger, was working on treatments for two rare forms of muscular dystrophy and used Claude to organize contracts, logistics, and experiments across eleven external labs. A possible treatment for one form went from an idea to promising results in mice in under eighteen months. He’s now joined Anthropic, and if the early results hold up, a drug could be ready for human trials as soon as late 2028.
From my own experience working with websites, online tools, and automation projects, this pattern feels familiar even outside medicine: the AI isn’t doing the creative or judgment-heavy part by itself. It’s clearing out the slow, repetitive overhead (the paperwork, the first-pass analysis, the thousands of variations nobody has time to check by hand) so the human expert can spend their attention where it actually matters. I’ve also seen, through research into medical imaging and AI that explains its own reasoning to doctors, how much unglamorous groundwork has to happen before a model can be trusted with something this serious. These case studies read the same way: a lot of verification sitting underneath each headline number. If you want the background on how that kind of AI reasoning gets checked, our guide on explainable AI and how AI reads medical scans cover the fundamentals.
What This Means for You
You don’t need to work in a lab for this to matter. It’s a preview of how AI is likely to show up in most serious technical fields over the next few years: not as a replacement for experts, but as a tool that handles scale (thousands of designs, thousands of pages) while people make the final calls. If you’re a student in biology, chemistry, or data science, these partnerships are a real signal of where hands-on AI skills are becoming genuinely valuable, not just nice to have on a resume. Anthropic also recently opened an Anthropic Guest Investigator Program for outside researchers in the life sciences, and our guide on how AI can help with research and productivity has more ways to apply this in your own work.
Common Questions
Is AI actually discovering new drugs on its own?
Not yet, and Anthropic doesn’t claim that. Every case study pairs Claude with human scientists who design the experiments and verify the results in the lab.
How far along are these treatments?
Mostly preclinical, meaning they’ve been tested in lab settings or animal models, not yet in human clinical trials. The furthest along, Mithril Medicine’s muscular dystrophy candidate, is targeting human trials around late 2028 if results continue to hold up.
Why does this matter outside of medicine?
The same pattern (AI handling large-scale analysis and paperwork so humans can focus on judgment calls) applies to research, engineering, and plenty of other technical fields, which is why it’s worth understanding even if you’re not in life sciences.
Final Takeaway
This isn’t a story about AI replacing scientists. It’s a story about AI removing the parts of scientific work that were never the interesting part to begin with: the repetitive testing, the paperwork, the thousands of variations nobody could check manually. If that holds up outside these six partnerships, it’s one of the more genuinely useful applications of AI we’ve seen so far, and one worth watching as these programs move from lab results toward real patients. You can read Anthropic’s full case studies directly at its research page on early progress in drug development.
by admin | Oct 23, 2026 | Research & Productivity
Picture a small research group studying a rare disease. They have a promising idea, but not the budget for a big AI lab’s compute, and not the time to become machine learning experts just to test one hypothesis. That gap, between a good research question and the resources to chase it, is exactly what Anthropic’s newest program is trying to close.
On October 22, 2026, Anthropic opened applications for a Guest Investigator Program aimed squarely at life sciences researchers. It is a small, practical idea: pair outside scientists directly with Anthropic’s own research team for a few months, give them free use of Claude, and publish whatever comes out of it together. If you follow AI in research at all, this one is worth knowing about.
What the Guest Investigator Program Actually Offers
According to Anthropic’s own announcement, this goes further than a simple API discount. Selected research groups work directly with Anthropic researchers on a problem the group chooses, and Anthropic runs its models and research harnesses for the project at no cost. The company says it will publish the outputs jointly with each group and open source the data and code that come out of it.
- Who can apply: principal investigators and their research groups at academic institutions, nonprofits, or government labs.
- What counts as eligible research: causal human biology, structural and computational molecular biology, medicinal chemistry, drug discovery, and clinical science.
- How long it lasts: collaborations run 8 to 12 weeks, with some extended if the work is going well.
- Timeline: applications stay open for about 14 days after the announcement, and selected groups hear back roughly 14 days after applications close.
One detail stands out if you have ever been wary of handing research data to a big AI company: Anthropic says it does not ask for data, either in the application or during the collaboration, and applications should only contain publicly available information. Investigators keep the rights to their data the whole way through, plus the rights to any follow-on research that comes later.
Why This Is Different From a Normal Research Grant
Most research funding gives you money and leaves the rest up to you. This program gives you something harder to buy: time with the people who actually built the model you are trying to use well. That matters more than it sounds. A lot of scientists know roughly what they want an AI tool to do, but not the fastest way to get there, which prompts work, which parts of a workflow should stay manual, where a model is likely to be wrong. Working alongside the team that built the tool shortens that learning curve considerably.
This also builds on two things Anthropic already had running. Its AI for Science program, launched back in 2025, gives qualifying researchers free API credits for high-impact projects, decided case by case based on scientific merit and how much AI could genuinely speed the work up. There is also a separate Life Sciences Verification Program that gives vetted scientists direct access to Anthropic’s most capable publicly available models for biology work. The Guest Investigator Program sits a level above both of those: instead of credits or model access alone, you get a defined, hands-on collaboration with a deadline and a shared publication at the end.
Why AI Labs Are Courting Scientists Right Now
This is part of a bigger pattern. OpenAI has its own Rosalind academic plan giving university labs free seats and gated access to a life-sciences focused model, which we covered in our guide to the Rosalind academic plan. Anthropic has separately been investing heavily in trust and safety work through programs like independent model evaluation, which we explained in our piece on who actually checks whether AI models are safe. Put together, the race among big labs has shifted. Building bigger models used to be the whole story. Now proving those models are useful, and safe enough to trust, for research that actually changes people’s lives matters just as much.
From my own experience helping people set up websites and online tools, I have noticed the same shift happening one level down, outside of elite research labs. Everyday small business owners and students are being handed free or cheap access to tools that used to require a specialist. The scale is different for a cancer researcher versus someone automating their invoicing, but the underlying idea is the same: AI companies have realized that giving real experts hands-on access, instead of just a generic chat window, is where the genuinely useful results come from.
Important tip: if you or someone you know runs a research group and this sounds relevant, read the eligibility list closely before applying. Anthropic is specific about the five research areas it wants (causal human biology, molecular biology, medicinal chemistry, drug discovery, and clinical science), and a strong application explains clearly how direct access to Anthropic’s researchers, beyond the model itself, would change what the project could achieve in 8 to 12 weeks.
What This Could Mean for Medical and Health Research
A program like this is especially interesting for anyone following AI in medicine, where the hardest problem usually is not “can the model get the right answer,” it is “can a doctor or researcher trust why it got that answer.” Explainability matters enormously in clinical science and drug discovery, where a wrong or unexplained result can waste months of lab work. Getting direct time with the people building these systems, rather than treating the model as a black box, is a meaningfully different way to close that trust gap than simply publishing a bigger benchmark score.
Common Questions
Do I need to already be famous in my field to apply? No. Anthropic says it is looking at the potential impact of the proposed project and how much AI could realistically accelerate it, rather than a researcher’s existing reputation alone.
Will Anthropic own my data or results? No. The announcement states that guest investigators keep the rights to their data throughout the project and to any independent follow-on research, and Anthropic does not request data as part of the application.
Is this the same as the Rosalind academic plan or the Life Sciences Verification Program? No, those are separate initiatives from OpenAI and Anthropic respectively that mainly provide model access or credits. This program adds direct, hands-on collaboration with Anthropic’s own researchers for a fixed period.
Final Takeaway
Free AI credits are nice, but a few months of direct help from the people who built the tool is a different kind of offer, and it is a sign of how seriously the big AI labs now take real scientific research, well beyond chatbots and coding assistants. If you are in life sciences research and have a question that keeps stalling for lack of the right tools, this is a short window worth looking into before it closes.
by admin | Oct 16, 2026 | Research & Productivity
If you have ever watched a university lab wait weeks for a bigger cloud-computing budget just to run one more experiment, you already know the real bottleneck in science is rarely a shortage of ideas. It is access. On October 15, 2026, OpenAI tried to chip away at that problem for a specific group of researchers with a new program called the Rosalind Academic Plan.
If you work in a lab, teach at a university, or just follow how AI is changing research, here is what the plan actually offers, who qualifies, and why it is worth paying attention to even if you will never apply for it yourself.
What Is the Rosalind Academic Plan?
The Rosalind Academic Plan is a new OpenAI program that gives eligible U.S. university labs free access to its commercial AI models, paired with GPT-Rosalind, OpenAI’s specialized model for life sciences, plus a workspace called Rosalind Workbench. Until now, GPT-Rosalind access had mostly gone to large companies and select government partners, so opening a path for academic labs is a genuine shift.
Each approved lab can activate up to 30 named seats at no charge, for up to 12 months, with usage limits attached. The offer covers subscription-style seats only. It does not include API access, so labs cannot wire the models directly into their own custom research software.
What Is GPT-Rosalind, and Why Isn’t It Automatic?
GPT-Rosalind launched back in April 2026 as the first model in a new OpenAI series built for scientific work. It is named after Rosalind Franklin, whose X-ray images were central to discovering the structure of DNA. OpenAI designed it to reason about molecules, proteins, genes, pathways, and disease biology, and to handle multi-step research tasks like literature review, experiment planning, and data analysis using scientific tools and databases. Early partners applying it to real workflows reportedly include Amgen, Moderna, the Allen Institute, and Thermo Fisher Scientific.
Here is the part that trips people up: getting a seat under the Rosalind Academic Plan does not automatically unlock GPT-Rosalind itself. That model needs a separate trusted-access review, on top of the lab’s approval for the plan. OpenAI is clearly treating a biology-tuned reasoning model as higher-stakes than a general chatbot, which tracks with how cautious the field has been about models that touch drug discovery and pathogen-adjacent research.
Who Can Actually Apply
Eligibility is reviewed at the lab level, not the individual level. OpenAI looks at:
- The lab lead’s identity, university appointment, and authority to oversee access
- The lab’s university affiliation and current research activities
- The intended use of the models and data
Labs at universities that already have an OpenAI Enterprise agreement apply through their institution. Labs at universities without one go through OpenAI’s own trusted-access route instead. OpenAI also states that research data shared through the plan is not used to train its models by default, which matters a lot if your work involves anything sensitive or unpublished.
Tip: before you plug any real experimental or patient-derived data into a new research AI tool, read the data-use and training policy yourself rather than trusting a headline summary of it. Policies like this get updated, and “not used to train by default” can still mean something different from “never touches our servers.”
The Bigger Pattern Behind the Headline
From my own experience working around websites, online tools, and digital projects, I have noticed that AI research access is splitting into two very different tracks right now. Broad discovery tools are opening up fast and wide, the way Google Scholar Labs expanded its AI research features to more users this year. But specialized, higher-stakes models like GPT-Rosalind are moving the opposite direction: more gated, more reviewed, more careful about who gets in.
That split makes sense once you think about what is at stake. A general research assistant that helps you summarize papers is a very different risk profile from a model fine-tuned to reason about disease pathways and drug design. If you are comparing everyday research tools rather than specialist lab software, our recent look at Elicit vs Gemini Notebook is a useful next read.
It is also a reminder that whatever AI tool you are using for research, the output still needs your judgment on top. That applies just as much to a specialized biology model as it does to a general chatbot summarizing a journal article. We covered the practical side of that in how to fact-check AI research answers before you cite them, and it is worth revisiting before any serious project, academic or otherwise.
What This Means for You
If you are not affiliated with a U.S. university lab, this specific program will not reach you directly. But it is still a useful signal: AI companies are increasingly willing to subsidize serious research use cases while keeping tighter control over who touches their most specialized models. If you are a student or early-career researcher, it is worth asking your supervisor or department whether your institution already has an OpenAI Enterprise agreement, since that changes which door you knock on.
Common Questions
Is the Rosalind Academic Plan free forever?
No. Approved labs get up to 30 seats free for up to 12 months, with usage limits. OpenAI has not said what happens after that period.
Does my university need an existing deal with OpenAI first?
Not necessarily. Universities with an OpenAI Enterprise agreement apply through their institution. Universities without one can apply through OpenAI’s separate trusted-access route.
Can an approved lab use GPT-Rosalind right away?
No. A seat under the plan covers OpenAI’s general commercial models. GPT-Rosalind itself needs an additional, separate trusted-access review.
Does the plan include API access for custom tools?
No. It covers subscription seats only, not API access, so labs cannot connect the models directly into their own research software through this plan.
Final Takeaway
The Rosalind Academic Plan is a narrow program on paper, limited to U.S. university labs, capped seats, and a one-year clock. But it says something broader about where AI in research is heading: more free access for people doing real scientific work, and more scrutiny over who gets the most powerful, specialized tools. Whether you are in a biology lab or just reading a paper with an AI assistant open in another tab, the same habit still applies: use the tool, then check its work yourself.
by admin | Oct 15, 2026 | Research & Productivity
You open twelve browser tabs, a stack of PDFs, and a half-finished spreadsheet, and you still cannot answer a simple question: what does the research actually say? If that sounds familiar, you have probably already tried an AI research tool to speed things up. Two of the most talked-about options right now are Elicit and Gemini Notebook, the tool most people still know by its old name, NotebookLM.
Both tools use AI to help you work through research faster, but they are built for different jobs. Picking the wrong one wastes time you were trying to save. Here is a plain-English look at what each one actually does, where it falls short, and which one fits your situation.
What Elicit Is Really Good At
Elicit is built for people doing serious literature work: students writing a thesis, researchers running a systematic review, or anyone who needs to find and summarize academic papers quickly. It searches across more than 138 million papers and over 500,000 clinical trials using semantic search, so you do not need to guess the exact keywords a paper might use.
- A Research Agent that gathers evidence from journals, clinical trials, and your own uploaded documents, then builds cited reports, tables, and even slides
- Systematic review support that automates screening and data extraction, with Elicit’s own figures suggesting researchers can save a large share of the time that step normally takes
- A Library to store and reuse sources across projects, plus Routines that keep you updated when new relevant research is published
- Sentence-level citations on AI-generated claims, so you can trace every summary back to its source
Elicit has a free Basic plan for casual searching and reading, with paid tiers that unlock exports, larger systematic reviews, and API access for heavier workloads. If your work involves citing sources properly, our guide on how to fact-check AI research answers before you cite them is worth reading alongside any tool you choose, Elicit included.
What Gemini Notebook (Formerly NotebookLM) Does Differently
Google renamed NotebookLM to Gemini Notebook in July 2026, though plenty of people still search for it by the old name, so we will use both here. The core idea has not changed: you upload your own sources, PDFs, notes, slides, websites, and Gemini Notebook answers questions strictly grounded in what you gave it, with citations pointing back to the exact passage.
- Source-grounded chat that will not wander off into made-up answers outside your uploaded material
- Audio and video overviews that turn your notes into a spoken discussion or a short explainer video
- Mind maps, flashcards, quizzes, and slide decks generated automatically from your sources
- A secure code execution environment per notebook, useful for data analysis grounded in the files you uploaded
- Syncing between the Gemini app and the standalone Gemini Notebook experience
Where Elicit goes out and searches the wider body of academic literature for you, Gemini Notebook stays inside the walls of whatever you feed it. That difference decides which tool actually helps you.
Quick tip: if you are not sure which job you are doing, ask yourself this: am I trying to find research I have not read yet (use Elicit), or am I trying to understand and organize research I already have (use Gemini Notebook)? That one question settles most of the confusion.
Elicit vs Gemini Notebook: Practical Scenarios
- Writing a literature review from scratch and need to discover relevant papers: Elicit
- You already have a folder of PDFs, lecture slides, or meeting notes and want a study companion: Gemini Notebook
- Running a formal systematic review that needs PRISMA-style screening: Elicit
- Turning dense research into an audio summary you can listen to on a commute: Gemini Notebook
- Extracting data into a table across dozens of papers: Elicit
- Building a quiz or mind map from your own course material to revise for exams: Gemini Notebook
From my own experience working with online tools and digital projects, the tools that save real time are the ones matched to the job in front of you, not the ones with the longest feature list. Match the tool to the task first, then worry about which one looks nicer.
Which One Should You Actually Pick?
If you are starting a research project and do not yet know what has already been published, start with Elicit. It will surface papers you would never have found by scrolling through Google Scholar manually, and the citation trail keeps your work honest. For deeper background on how these grounded-answer systems work under the hood, see our explainer on what RAG in AI actually means, since both tools lean on similar retrieval techniques.
If you already have the material, your own PDFs, lecture notes, or a pile of saved articles, and you want to understand, organize, and revise it faster, Gemini Notebook is the better fit. Our guide on how to chat with a PDF using AI covers a similar workflow if you want more free and low-cost options in the same space.
Plenty of students and researchers end up using both: Elicit to find and screen the literature, then Gemini Notebook to turn the papers they have collected into something they can actually study from. If you want a wider view of how AI fits into a research workflow beyond these two tools, our piece on how AI can help with research and productivity is a good next read.
Common Questions
Is Elicit free to use? Yes, Elicit has a free Basic plan with unlimited search across its paper database and limited use of its Research Agent and Reports features. Paid plans add exports, larger systematic reviews, and higher usage limits.
Did NotebookLM really change its name? Yes. Google announced the rename to Gemini Notebook in July 2026. It is the same underlying product, now more tightly connected to the Gemini app and Google Search.
Can I trust the citations these tools give me? Both tools link claims back to source text, which is a good starting point, but you should still open the original source before citing it in your own work. Our guide on fact-checking AI research answers walks through exactly how to do that.
Final Takeaway
Elicit and Gemini Notebook are not really competitors, they solve two different problems. Elicit helps you find research you have not seen yet. Gemini Notebook helps you make sense of research you already have. Figure out which problem you are facing today, pick the matching tool, and you will get more done in the next hour than an afternoon of random tab-switching ever managed.
by admin | Oct 8, 2026 | Research & Productivity
Picture this: it’s late, you’re finishing a paper, and an AI assistant just handed you three perfect-sounding sources to back up your argument. You drop them into your reference list and move on. A week later, your supervisor can’t find one of those papers anywhere, because it doesn’t exist.
That isn’t a rare glitch. It’s one of the most common and least talked-about risks of using AI for research, and it even caught out a well-known misinformation expert in a real court case. AI assistants like ChatGPT, Gemini, and Claude are genuinely useful for study and research, but they also “hallucinate”: they sometimes invent facts, authors, and entire papers that sound completely real. This guide shows you how to fact-check AI research answers before you cite them, using a method that takes minutes, not hours.
Why AI Tools Sometimes Invent Sources
AI hallucination isn’t random bad luck, it’s built into how these models are trained. OpenAI has explained that language models learn by predicting the next word in huge amounts of text that has no built-in “true or false” label attached to it. Common patterns, like grammar and spelling, improve a lot as models get bigger. But specific, low-frequency facts, like the exact volume number of a journal article, often can’t be learned reliably, so the model fills the gap with something plausible-sounding instead.
OpenAI also points out that the way models are tested makes this worse: standard accuracy scoring rewards a confident guess over an honest “I don’t know,” so models learn to guess rather than admit uncertainty. OpenAI says newer models hallucinate less, especially when reasoning carefully, but the problem hasn’t disappeared.
A Real Case: When a Misinformation Expert Got Caught by AI
This isn’t just a theoretical risk. In late 2024, Stanford researcher Jeff Hancock, founder of the university’s Social Media Lab, submitted a court declaration supporting a Minnesota law on AI deepfakes. According to reporting in the Stanford Daily, Hancock later admitted he had used ChatGPT to help organize his citations, and the tool invented two references that didn’t exist and misattributed a third to the wrong authors. He said his core arguments were still backed by real research, but the fabricated citations gave opposing lawyers grounds to challenge the filing. If a misinformation researcher can miss fake AI citations in a federal court filing, the rest of us should assume we can too.
From my own experience working with websites, cybersecurity, and online tools, I’ve seen the same pattern in AI-suggested code and security fixes: the answer sounds confident and specific, but it hasn’t actually been checked against a real, working source. Confidence is not the same as accuracy.
How to Fact-Check AI Research Answers in 5 Simple Steps
A university library guide on checking AI-generated citations lays out a short process that works well for any AI research answer, not just formal references:
- Check that the source has the right details. A journal article needs an author, title, journal name, volume, and issue. A book needs a publisher. If key details are missing, treat it as unverified.
- Watch for red flags. Broken or dead links, a citation format that doesn’t match standard styles, or vague phrasing like “a 2023 study found” with no named source are all warning signs.
- Search for it yourself. Paste the exact title in quotation marks into Google Scholar or a regular search engine. If nothing matches, the source is probably invented.
- Match every detail. Confirm the author names, publication date, journal, and volume or issue number against what you actually find, not just the title.
- When you’re still unsure, ask a librarian or switch tools. Librarians can verify sources and track down hard-to-find papers, and some AI tools are far less likely to invent sources in the first place.
Quick tip: paste the exact title of any AI-suggested source into Google Scholar in quotation marks. If nothing comes up, treat the citation as fake until you can prove otherwise.
Tools That Make Verification Easier
Not all AI research tools carry the same risk. General chatbots generate text freely, which is exactly how fabricated citations slip in. Source-grounded tools work differently: they search real, indexed material and show you where an answer came from, so you can check it in seconds.
Our guide to AI research tools like NotebookLM and Elicit covers how these grounded tools cite their sources directly, and Google Scholar Labs builds its AI answers from indexed academic papers rather than generating them freely. For the bigger picture on using AI without losing your own judgement, read AI and critical thinking, and for a broader starting point on using AI in your coursework, see how AI can help with research and productivity.
Common Questions
Do all AI tools hallucinate citations?Most general-purpose chatbots can, since they generate text from patterns rather than a verified database. The risk is lower with tools that search and cite real indexed sources, but it’s never zero.
Is it still safe to use AI to find research sources?Yes, as long as you verify what it gives you. AI is excellent for discovering leads and summarizing papers. The problem isn’t using AI, it’s citing its output without checking it first.
What’s the fastest way to check a citation?Copy the exact title into Google Scholar in quotation marks. A real paper usually appears in the first few results. If it doesn’t, dig further before you trust it.
Final Takeaway
AI can speed up your research dramatically, but it can’t replace the five minutes it takes to check whether a source is real. Build that check into your routine every time, and you get the speed of AI without the risk of citing a paper that was never written in the first place.
by admin | Oct 1, 2026 | Research & Productivity
If you have ever typed a research question into Google Scholar and gotten back a wall of a hundred papers with no idea where to start, you are not alone. That gap between “I have a question” and “I have the right ten papers to read” eats up more time than almost anything else in research work. Google has been quietly trying to close that gap with a tool called Google Scholar Labs, and it just got a big upgrade.
If you are a student, a grad researcher, or anyone who reads academic papers for a living, this is worth five minutes of your time.
What Is Google Scholar Labs?
Scholar Labs is an AI search mode built into Google Scholar. Instead of just matching keywords, it reads your actual question, works out the different angles hiding inside it, and then searches across Scholar to find papers that address those angles together.
Google gives a simple example: if you ask about caffeine’s effect on short-term memory, a keyword search gives you papers on caffeine and separate papers on memory. Scholar Labs tries to surface papers that connect the two, and for each result it explains how that paper actually answers your question.
It first launched in November 2025 to a small group of logged-in users. You can try it directly at scholar.google.com/scholar_labs/search.
What Changed in the Latest Update
In June 2026, Google rolled out a significant update to Scholar Labs, and the numbers are the headline:
- Results return about 10 times faster than the original version
- The tool scans up to 3 times more papers per search
- Logged-in users can now run 10 times more searches per day
Just as important, access widened from a small test group to all logged-in Google Scholar users. The update launched in English first, with other languages planned.
You can also ask follow-up questions once you get results, which turns a single search into something closer to a conversation with your reading list. That matters if your first question was too broad or you need to chase a specific detail, like a sample size or a methodology, across several papers.
How to Use It for Your Own Research
Getting value out of Scholar Labs comes down to how you phrase the question, not just what topic you search.
A plain keyword search still works fine when you already know the paper or author you want. Scholar Labs earns its keep when your question has more than one moving part. Try something closer to “how does remote work affect employee mental health across different industries” instead of just “remote work mental health.” The more structure you put into the question, the more structure you get back in the answer.
A few practical ways to use it:
- Early-stage literature review, to get a first map of a topic before you commit to a direction
- Checking whether your research question has already been well covered, before you propose it
- Verifying a claim or citation while you are drafting, by asking the specific question your sentence depends on
Important tip: treat Scholar Labs as a faster way to find candidate papers, not as a replacement for reading them. It is still an experimental AI feature, and the usual rules apply: check the actual paper, check the date, and check who funded or published it before you cite anything.
From working on websites and digital tools for a few years now, the tools that stick are rarely the flashiest ones. They are the ones that remove one annoying step from a task you already do every week. Scholar Labs fits that description for anyone doing a literature review: it does not replace your judgment, it just gets you to the reading list faster.
Where This Fits With Other AI Research Tools
Scholar Labs is one piece of a bigger shift toward AI-assisted research. If you want the wider picture, What Is AI Deep Research? explains how tools like this fit into a full research workflow, and OpenAI Built an AI Research Intern covers a similar idea from a different company.
If you are already using reference managers, Zotero’s new read-aloud AI feature is a good companion tool once Scholar Labs has helped you find the papers worth reading closely. And once you have your reading list, this guide to summarizing research papers with AI walks through getting through them faster without skipping the important parts.
For the official details straight from Google, see the Google Scholar blog’s launch post and the June 2026 update announcement.
Common Questions
Is Google Scholar Labs free to use?Yes. It is available to any logged-in Google account holder through Google Scholar, with no separate subscription.
Does it replace Google Scholar’s normal search?No. Scholar Labs is a separate AI mode you access through its own page. Regular Google Scholar search still works exactly as before.
Can I trust the papers it recommends?Treat it the same way you would treat any search tool’s results: a useful starting point, not a final answer. Always check the original paper before citing it.
Is it available outside English?The June 2026 update launched in English first. Google has said other languages are planned, but no firm dates have been announced.
Final Takeaway
Google Scholar Labs will not write your literature review for you, and it should not. What it does is cut down the time between asking a real research question and finding papers that actually address it, which is where most of us lose hours we do not have. If you do any kind of academic or professional research, it is worth bookmarking and testing on your next real question.
